But now, weve created new problems
And the results are finally accessible to people right here in Lake Worth, Florida
examined the impact of GSH synthesis inhibitors on the cytotoxicity of cisplatin and gemcitabine in bile duct cancer cells [47]
Coverage at NY Times, front page today and my input to that piece Instead of focusing on banning things a small subset of people are using and seeing benefit in, can we focus on modernizing the clinical trial system to promote efficient drug development
HbA1c well above target despite oral therapy Insulin or GLP-1 agonist depending on patient preference, weight, and risk profile
Functions as a short, cellpenetrating peptide capable of crossing cell and even nuclear membranes, which supports efficient intracellular and intranuclear access in vitro and in vivo